SNPwatch: Enzyme Deficiency May Protect Against Serious Hepatitis C Treatment Side Effect

People chronically infected with the hepatitis C virus currently have only one treatment option:  a combination of polyethylene glycol (PEG)-ylated interferon alpha and ribavirin (RBV).   Not only does this drug regimen fail to eradicate the virus in about half of all patients who receive it, but even when it ...

Read more

Return to top